HSD17B13-IN-5 (Compound 96) is an inhibitor of hydroxysteroid 17beta-dehydrogenase 13 (HSD17B13) with a Ki value of 50 nM for the estradiol substrate LCMS. HSD17B13-IN-5 can be used in the research of liver diseases, metabolic disorders, or cardiovascular diseases such as NAFLD or NASH, or drug-induced liver injury (DILI)[1].
Molecular Weight:
574.93
Formula:
C26H15ClF4N4O3S
Target:
17beta-HSD
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
